The previously alarmingly high death rate from prostate cancer in the United States has declined for several of the last few years, but the disease still claims too many lives.
There is little doubt that the cancerous disease will strike an estimated three hundred thousand men this year alone, whilst proving fatal in perhaps ten percent of that number of men, which if you ask me is still way too alarmingly high. It remains without doubt the second leading cancer killer of American men, right behind lung cancer.
Based on these facts, better ways yet to manage this disorder, especially prevalent in men over 65 years of age, are being sought all the time, at the end of which, the perfect or ideal cure for prostate type of cancer is hoped for. Before the cure, though, and before better treatment techniques, there is also the need for improved diagnostic processes for prostate cancer.
The most reliable test that will fully confirm the diagnosis of prostate cancer is a biopsy of the prostate gland of the patient. This requires the removal of tiny harmless pieces of the prostate gland for close observation underneath the scrutiny of a microscope, by which means the doctor can identify cancerous tissue from living cells and they can establish or refute the presence of the disease.
Prior to the biopsy, however, several other tools may be employed in order to collect a lot of information about the condition of the prostate gland and of the urinary tract - information that may determine what lengths need to be explored in the diagnostic process.
iAutoblog the premier autoblogger software
No comments:
Post a Comment